Clinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: An observational study

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Gouveia, Edilane L ^a   Reis, Joice N ^a,b   Flannery, Brendan ^c   Cordeiro, Soraia M ^a   Lima, Josilene B T ^a   Pinheiro, Ricardo M ^a   Salgado, Kátia ^d   Mascarenhas, Ana V ^d   Carvalho, M Gloria ^e   Beall, Bernard W ^e   Reis, Mitermayer G ^a   Ko, Albert I ^a,f  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c PAN AMERICAN HEALTH ORGANIZATION   (Brazil)

^d Hospital Couto Maia   (Brazil)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; PNEUMOCOCCUS VACCINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BETA LACTAM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BRAZIL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; FATALITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PENICILLIN RESISTANCE; PNEUMOCOCCAL MENINGITIS; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE; BACTERIAL MENINGITIS; DRUG EFFECT; HOSPITAL; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; NEWBORN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81355147126     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-323     Document Type: Article

References (36)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374(9693):893-902. 10.1016/S0140-6736(09)61204-6, 19748398.
2. Therapy for children with invasive pneumococcal infections American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1997, 99(2):289-299. Therapy for children with invasive pneumococcal infections.
3. Kaplan SL, Mason EO. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998, 11(4):628-644. 88901, 9767060.
4. Begg N, Cartwright KA, Cohen J, Kaczmarski EB, Innes JA, Leen CL, Nathwani D, Singer M, Southgate L, Todd WT, Welsby PD, Wood MJ. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect 1999, 39(1):1-15. 10.1016/S0163-4453(99)90095-6, 10468122.
5. World Health Organization Antimicrobial and support therapy for bacterial meningitis in children. Report of the meeting of 18-20 June 1997 1997, Geneva, Switzerland. HO/CHD/98.6; WHO/EMC/BAC/98.2, World Health Organization.
6. McCracken GH. Rich nations, poor nations, and bacterial meningitis. Lancet 2002, 360(9328):183. 10.1016/S0140-6736(02)09499-0, 12133648.
7. Mwangi I, Berkley J, Lowe B, Peshu N, Marsh K, Newton CR. Acute bacterial meningitis in children admitted to a rural Kenyan hospital: increasing antibiotic resistance and outcome. Pediatr Infect Dis J 2002, 21(11):1042-1048. 10.1097/00006454-200211000-00013, 12442027.
8. Molyneux E, Riordan FA, Walsh A. Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Ann Trop Paediatr 2006, 26(1):29-37. 10.1179/146532806X90583, 16494702.
9. World Health Organization Standardized treatment of bacterial meningitis in Africa in epidemic and non epidemic situations. 2007, WHO/CDS/EPR/2007.3, World Health Organization.
10. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009, 373(9659):240-249. 10.1016/S0140-6736(08)61762-6, 19042012.
11. Ko AI, Reis JN, Coppola SJ, Gouveia EL, Cordeiro SM, Lobo TS, Pinheiro RM, Salgado K, Ribeiro Dourado CM, Tavares-Neto J, Rocha H, Galvao Reis M, Johnson WD, Riley LW. Clonally related penicillin-nonsusceptible Streptococcus pneumoniae serotype 14 from cases of meningitis in Salvador, Brazil. Clin Infect Dis 2000, 30(1):78-86. 10.1086/313619, 10619737.
12. Secretariat for Health Surveillance Meningitis. 2004, Brasilia, Brazil: Ministry of Health, 7, Secretariat for Health Surveillance.
13. Reis JN, Cordeiro SM, Coppola SJ, Salgado K, Carvalho MG, Teixeira LM, Thompson TA, Facklam RR, Reis MG, Ko AI. Population-based survey of antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from meningitis patients in Salvador, Brazil. J Clin Microbiol 2002, 40(1):275-277. 10.1128/JCM.40.1.275-277.2002, 120107, 11773131.
14. Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol 1994, 32(1):159-163. 262988, 8126173.
15. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: 18th informational supplement. CLSI document M100-S18 2008, Wayne, PA: Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute.
16. Friedland IR, Shelton S, McCracken GH. Chloramphenicol in penicillin-resistant pneumococcal meningitis. Lancet 1993, 342(8865):240-241.
17. Klugman KP, Koornhof HJ, Friedland IR. Antibiotic resistance in pneumococcal meningitis. Lancet 1992, 340(8816):437-438.
18. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992, 339(8790):405-408. 10.1016/0140-6736(92)90087-J, 1346668.
19. Andes D, Craig WA. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother 1998, 42(9):2375-2379. 105836, 9736566.
20. Lebel MH, McCracken GH. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics 1989, 83(2):161-167.
21. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 1992, 11(9):694-701. 10.1097/00006454-199209000-00002, 1448306.
22. Duke T, Michael A, Mokela D, Wal T, Reeder J. Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?. Arch Dis Child 2003, 88(6):536-539. 10.1136/adc.88.6.536, 1763115, 12765927.
23. Brandileone MC, Casagrande ST, Guerra ML, Zanella RC, Andrade AL, Di Fabio JL. Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage. J Med Microbiol 2006, 55(Pt 5):567-574.
24. Brandileone MC, Casagrande ST, Guerra ML, Zanella RC, de Andrade AL, Di Fabio JL. Increase in penicillin resistance of invasive Streptococcus pneumoniae in Brazil after 1999. J Antimicrob Chemother 2005, 56(2):437-439.
25. Weinstein MP, Klugman KP, Jones RN. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis 2009, 48(11):1596-1600. 10.1086/598975, 19400744.
26. Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003, 37(2):230-237. 10.1086/377534, 12856216.
27. Hortal M, Lovgren M, de la Hoz F, Agudelo CI, Brandileone MC, Camou T, Casagrande S, Castaneda E, Corso A, Echaniz G, Hormazabal JC, Pace J, Palacio R, Perez-Giffoni G, Ruvinsky R, Di Fabio JL. Antibiotic resistance in Streptococcus pneumoniae in six Latin American countries: 1993-1999 surveillance. Microb Drug Resist 2001, 7(4):391-401. 10.1089/10766290152773400, 11822779.
28. Brouwer MC, Read RC, van de Beek D. Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 10(4):262-274.
29. Peltola H, Roine I, Fernandez J, Zavala I, Ayala SG, Mata AG, Arbo A, Bologna R, Mino G, Goyo J, Lopez E, de Andrade SD, Sarna S. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007, 45(10):1277-1286. 10.1086/522534, 17968821.
30. Sinner SW, Tunkel AR. Antimicrobial agents in the treatment of bacterial meningitis. Infect Dis Clin North Am 2004, 18(3):581-602. ix, 10.1016/j.idc.2004.04.005, 15308277.
31. Agudelo CI, Castaneda E, Corso A, Regueira M, Brandileone MC, Brandao AP, Maldonado A, Hormazabal JC, Tamargo I, Echaniz-Aviles G, Soto A, Viveros MG, Hernandez I, Chamorro G, Weiler N, Sanchez J, Feris JM, Camou T, Garcia G, Spadola E, Payares D, Gabastou JM, Di Fabio JL. [Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000-2005]. Rev Panam Salud Publica 2009, 25(4):305-313.
32. Castanheira M, Jones RN, Silbert S, Brandileone MC, Sader HS. Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America. Microb Drug Resist 2003, 9(4):345-351. 10.1089/107662903322762770, 15000740.
33. Arditi M, Mason EO, Bradley JS, Tan TQ, Barson WJ, Schutze GE, Wald ER, Givner LB, Kim KS, Yogev R, Kaplan SL. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998, 102(5):1087-1097. 10.1542/peds.102.5.1087, 9794939.
34. Buckingham SC, McCullers JA, Lujan-Zilbermann J, Knapp KM, Orman KL, English BK. Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes. Pediatr Infect Dis J 2001, 20(9):837-843. 10.1097/00006454-200109000-00003, 11734760.
35. Fiore AE, Moroney JF, Farley MM, Harrison LH, Patterson JE, Jorgensen JH, Cetron M, Kolczak MS, Breiman RF, Schuchat A. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis 2000, 30(1):71-77. 10.1086/313606, 10619736.
36. Castaneda E, Agudelo CI, Regueira M, Corso A, Brandileone MC, Brandao AP, Maldonado A, Hormazabal JC, Martinez IT, Llanes R, Sanchez J, Feris JM, Echaniz-Aviles G, Carnalla-Barajas MN, Terrazas MG, Monroy IH, Chamorro G, Weiler N, Camou T, Gabarrot GG, Spadola E, Payares D, Gabastou JM, Di Fabio JL, de la Hoz F. Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000-2005. Pediatr Infect Dis J 2009, 28(9):e265-270. 10.1097/INF.0b013e3181a74b22, 19710581.